Yaacov-Garbeli Dana's Form 4 filing
Entera Bio Ltd. (ENTX) · filed Aug 7, 2026
- Accession no.
- 0001178913-26-003953
- Filed
- Aug 7, 2026, 4:20 PM ET
- Trade date
- Aug 7, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 0 non-derivative transactions and 1 derivative transaction. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yaacov-Garbeli DanaCIK 0001909822 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Ordinary Shares, par value NIS 0.0000769 per share | AGrant or awardAcquired | +140,000 | $0.00 | $0 | 140,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.